Blower TR, et al. (2019) A complex suite of loci and elements in eukaryotic type II topoisomerases determine selective sensitivity to distinct poisoning agents. Nucleic Acids Res 47(15):8163-8179 PMID:31287876
West KL, et al. (2000) Mutagenesis of E477 or K505 in the B' domain of human topoisomerase II beta increases the requirement for magnesium ions during strand passage. Biochemistry 39(6):1223-33 PMID:10684600
Turnbull RM, et al. (1999) Carbamate analogues of amsacrine active against non-cycling cells: relative activity against topoisomerases IIalpha and beta. Cancer Chemother Pharmacol 44(4):275-82 PMID:10447574
Meczes EL, et al. (1997) Complementation of temperature-sensitive topoisomerase II mutations in Saccharomyces cerevisiae by a human TOP2 beta construct allows the study of topoisomerase II beta inhibitors in yeast. Cancer Chemother Pharmacol 39(4):367-75 PMID:9025779
Wasserman RA, et al. (1993) Use of yeast in the study of anticancer drugs targeting DNA topoisomerases: expression of a functional recombinant human DNA topoisomerase II alpha in yeast. Cancer Res 53(15):3591-6 PMID:8393377